Procter & Gamble Hygiene and Health Care Ltd

Overview

• Standalone BRSR for FY2025-26 disclosures.
• Manufacture and sale of branded FMCG; healthcare products and sanitary napkins comprise 100% turnover.
• Goa plant; 24 locations nationwide.
• Exports 3.19% of turnover; pan-India presence across 28 states and 8 UTs; 14 countries.
• Assurance: reasonable assurance by Kalyaniwalla & Mistry LLP.

Key ESG Risks & Opportunities

• Plastic packaging waste risk; plan to design recyclable/reusable packaging and meet EPR obligations.
• Diversity and Inclusion treated as opportunity; integrated Equality & Inclusion efforts.
• Community impact via P&G Shiksha CSR; scalable, aligned with National Education Policy.

Governance & Policy Highlights

• WBCM adopted as BR policy; Board approval noted in 2017.
• MD oversees BR policy implementation; no dedicated sustainability committee.
• Anti-bribery policy in place; regular trainings; WBCM link referenced.
• Vigil Mechanism reviewed quarterly by Audit Committee.
• No material fines or penalties in FY2025-26.
• Assurance: reasonable assurance by Kalyaniwalla & Mistry LLP.

Social Responsibility & Workforce

• Permanent staff 241; total workers 471; female representation 36% and 4% respectively.
• Turnover: permanent 8.8%; workers 2.7%.
• LTIFR: employee 0; worker 0.72; one worker injury.
• 100% of employees/workers have health insurance coverage.
• Wages: females 27% of total wages.
• Training: 100% coverage for HS&E and anti-bribery training.
• WBCM certifications obtained annually for managers.
• Return-to-work/retention on parental leave: 100% for both groups.
• Grievance mechanism: 24x7 Worldwide Business Conduct Helpline.
• Board female representation 22.22%; KMP female 33.33%.

Environmental Performance

• Energy: non-renewables electricity 50,333.83 GJ; fuel 1,858.42 GJ; total 52,192.25 GJ.
• Energy intensity: 0.12 GJ per lakh turnover; PPP-adjusted 2.39.
• Scope 1: 161.91 tCO2e; Scope 2: 10,010.84 tCO2e; total 10,172.75 tCO2e.
• Market-based Scope 2 emissions NIL due to RECs.
• Waste: plastic 1,971.53 MT; total waste 3,096.01 MT; 3,167.97 MT recycled.
• Goa plant zero landfill manufacturing waste.
• Circular water: 5,659 KL via condensate recovery and ETP recycle.
• Water withdrawal 16,520 KL; consumption 7,965 KL; intensity 0.04 KL per lakh turnover.
• Water intensity PPP: 0.78 KL/USD lakh; PPP-adjusted.
• Certifications: Goa plant ISO 9001:2015; ISO 13485:2016; BIS IS 5405:2019.
• External assurance: Kalyaniwalla & Mistry LLP for FY2025-26.

Stakeholder Engagement & Complaints

• Key stakeholder groups: employees, investors, consumers, customers, suppliers, government/regulators, community.
• Engagement channels: in-person/virtual, email; frequency: ongoing/annual.
• Communities: Nil complaints; Employees: 4 filed, 1 pending.
• Customers: 1 filed, 1 pending.
• Value chain partners: 11 filed, 1 pending.
• Shareholders: 12 complaints filed; none pending.
• Investors: Nil complaints; engagements via AGM, updates, and ballots.

Other Notable Metrics

• Inputs from MSMEs: 9% direct; 86% sourced within India.
• Sales concentration: 91.4% to dealers; top 10 dealers 59.5% of dealer sales.
• RPTs: purchases from related parties 45%; sales to related parties 3%.
• 100% of product turnover discloses environmental and social parameter information.
• Product recalls: none; consumer complaints: 1229; advertising complaints: 5; data privacy breaches: none.
• Data/privacy/cybersecurity framework in place; privacy policy available; no breaches.

agm details

• 62nd AGM on Sep 8, 2026; via video conference; registered office deemed venue.
• Record date Sep 1, 2026; remote e-voting Sep 4–7, 2026.
• Final dividend proposed ₹60 per share; payable by Oct 6, 2026, subject to approval.
• Notice and annual report circulated electronically; hard copy on request.

resolutions (to be put to vote)

• Adopt Audited financial statements and directors' and auditors' reports (ordinary).
• Interim dividend paid; declare final dividend for the year (ordinary).
• Re-appoint Pramod Agarwal as Non-Executive Director (retires by rotation).
• Appoint Srividya Srinivasan as Whole-time Director for five years with up to ₹5 crore salary and LTIP.
• Ratify remuneration to Cost Auditor for 2026-27: ₹10 lakhs plus out-of-pocket expenses.
• Approve material related party transaction with GDOPL for contract manufacturing up to ₹1000 crore annually for five years.

dividend status

• Interim dividend of ₹195 per share (₹25 one-time) paid 26 Feb 2026.
• Total dividend for the year ₹255 per share (interim + final).
• Final dividend proposed ₹60 per share; subject to AGM approval.

director changes / appointments

• Srividya Srinivasan appointed as Whole-time Director and CFO from 1 July 2026.
• Gaurav Bhartia ceased CFO; Srinivasan appointed CFO from 1 July 2026.
• Ghanashyam Hegde ceased Executive Director and Company Secretary; redesignated as Non-Executive Director from 1 July 2026.
• Pramod Agarwal to retire by rotation; eligible for re-appointment.

auditors

• Statutory Auditor: M/s Kalyaniwalla & Mistry LLP; five-year term to end at 63rd AGM.
• Cost Auditor: Ashwin Solanki & Associates; remuneration ₹10 lakhs for 2026-27.
• Internal Auditor: Pooja Bhutra appointed for 2025-26.
• Statutory audit fees: ₹170 lakhs for FY 2025-26.

material related party transactions

• Related party: GDOPL; contract manufacturing transition to contract manufacturing.
• RPT with GDOPL up to ₹1000 crore annually for five years.
• FY2025-26 RPT with GDOPL totaled ₹216.67 crores.

AGM schedule

• AGM date on September 8, 2026.
• Record date for AGM and dividend payment: September 1, 2026.
• Dividend, if approved at AGM, payable by October 6, 2026.

Financial highlights

• Sales ₹901 crore, down 5% YoY.
• PAT ₹126 crore, affected by commodity-cost fluctuations.

Cost and spend

• Advertising and promotional spend increased versus prior year.

Strategic investments

• Investing behind innovation and brands for long-term competitiveness.

Strategy and outlook

• Integrated Growth Strategy focuses on daily-use categories with value and product superiority.
• Geopolitical environment remains challenging.

Financial results approved

• Unaudited standalone results for quarter ended 30 June 2026 approved.
• Ind AS 34 framework applied; reviewed by Audit Committee and Board on 29 July 2026.
• Limited Review Report by Kalyaniwala & Mistry LLP furnished.

Audit and regulatory disclosures

• Review conducted under SRE 2410; no material misstatement evident.
• March 31, 2026 figures are balancing figures not audited.
• Reported per SEBI LODR Regulation 33.

Segment and corporate structure

• Operating segments consolidated into a single primary segment; no subsidiaries or JV.
• Company has no subsidiaries, associates, or joint ventures.

Board governance and timing

• Board meeting held on July 29, 2026; results approved.

AGM schedule

• AGM date: September 2, 2026 (Wednesday).
• Record date for AGM and dividend: August 26, 2026 (Wednesday).
• Dividend, if approved at AGM, payable by September 30, 2026.

Processing confirmation and ownership updates

• Securities received for dematerialisation during the reporting quarter were processed and confirmed to the depositories.
• Certificates' securities have been listed on stock exchanges where the earlier issued securities are listed.
• Physical dematerialisation certificates were mutilated and cancelled after verification; the depository's name was substituted as owner within timelines.

Cessation of Sales Head

• Type of change: cessation as Sales Head.
• Name and designation: Flavia Peter Machado, Sales Head.
• Effective date: close of business July 31, 2026.
• Reason: taking up assignment as Senior Vice President - Korea at P&G from August 1, 2026.
• Notes: no other material reasons disclosed.

Management change

• Girish Kalyanaraman accepted a change in assignment at P&G effective July 1, 2026.
• He will cease as category leader for the feminine hygiene business.
• He will leave the company's senior management team at close of business June 30, 2026.

Meeting Details

• Board meeting scheduled for May 28, 2026

Key Agenda Items

• Approval of audited financial statements for FY ending March 31, 2026
• Consideration of recommendation for final dividend